not suitable for any other modality of treatment; patient's preference; and residual AVM after failed radiosurgery. Treatment was performed using a 201-source 60 Co Gamma Knife unit.
Treatment was performed using standard radiosurgical techniques. The stereotactic frame was fixed to the patient's head after local anesthesia was induced (general anesthesia was used in children < 8 years of age or in uncooperative patients) and the position of the frame was adjusted on the head to bring the AVM nidus as close to the center of the frame as possible. All the patients underwent angiography along with MR imaging of the brain for stereotactic localization of the AVM. The software used for dose planning was Leksell Gamma Plan (Elekta Instruments, Inc.). The dose applied to the margin in the majority of cases was 25 Gy (using 50% isodose lines). Lower doses were given for lesions located in critical areas like the basal ganglia/thalamus and for large-volume AVMs.
Patients were evaluated clinically every 6 months after the treatment. The MR imaging and/or CT scanning in the follow-up period was done only in symptomatic patients (those with new neurological deficits after GKS, worsening of previous deficits, headache, suspected rebleeding, and so on) and for evaluation of response to treatment in patients with radiation edema. Hemorrhage was defined as a clinically symptomatic event such as sudden headache, seizure, focal deficits, death, or a combination of these, along with signs of fresh bleeding from the previously diagnosed AVM detected using MR imaging or CT studies. Follow-up angiography was performed at 2 years after GKS (some patients were advised to have an angiography study done earlier than 2 years in the initial phase of the treatment or if MR imaging findings suggested complete obliteration), and yearly thereafter in the presence of residual AVM, until 4 years posttreatment. The presence of a residual AVM on an angiogram even after 4 years post-GKS was considered to be radiosurgical failure, and a second treatment (either radiosurgical or embolic) was performed depending on residual AVM characteristics. Total angiographic obliteration was defined as the absence of abnormal vessels in the former nidus, or the disappearance or normalization of draining veins from the area. For all patients who did not show up for follow-up evaluation, we tried to contact them by mail or phone if possible and to update the data in the database. Data for patients with incomplete angiographic follow-up were censored back to their last follow-up evaluation.
Statistical Analysis
Statistical analysis was performed using STATA 9.0 (StataCorp LP). Data are presented as the number (with the percentage in parentheses) and median (with the range in parentheses) as appropriate. The differences in proportions were compared using the chi-square test. The Kaplan-Meier method was used to calculate the probability of hemorrhage-free survival. A probability value < 0.05 was considered statistically significant.
Results
The clinical characteristics of the 14 patients who sustained hemorrhage as well as the overall group are depicted in Table 1 . The details of the patients sustaining a postradiosurgical hemorrhage are shown in Table 2 . Follow-up angiography was performed at regular intervals to document complete obliteration. Total follow-up ranged from 6 to 121 months. Fourteen AVMs (2.8%) bled following GKS during the latency time in the analyzed period. None of the patients suffered a hemorrhage after angiography demonstrated complete AVM obliteration. The 14 patients who sustained postradiosurgical hemorrhage formed the study group, and the angioarchitecture, treatment parameters, disease management, and outcome in these individuals were evaluated in detail. Except for 2 patients who presented with an intraventricular hemorrhage the rest all had suffered an intracerebral hemorrhage. Due to their relatively well-preserved neurological status, in most of these patients the AVMs were managed conservatively to treat symptoms of raised intracranial pressure. Two patients required surgery; evacuation of the hematoma was done in one and a decompressive craniectomy was performed in the other; the bone flap was eventually replaced after the resolution of raised pressure symptoms in the patient who underwent bone flap removal. There were no deaths in patients who suffered a hemorrhage after GKS. None of the patients bled more than once after GKS. The distribution of hemorrhage-free survival after GKS is shown in the Kaplan-Meier plot (Fig. 1) ; the probability of sustaining a hemorrhage was maximum in the 1st year after GKS. Eight patients had their AVM obliterated after various intervals after the first GKS despite the rebleeding, and were symptom free at their last follow-up (Fig. 2) . Two patients who suffered hemorrhages post-GKS underwent repeat radiosurgery due to persistent nidus even > 4 years after the first GKS treatment (Fig. 3) ; one of them had total obliteration of the nidus by 2 years after the second radiosurgical treatment, whereas the second patient was lost to follow-up after the repeat radiosurgical procedure. The rest of the 4 patients were neurologically stable and were awaiting angiography for assessment of the status of AVM. Following rebleeding, the neurological status remained unchanged in majority of the patients (12 of 14), whereas it deteriorated, with persistence of mild deficit and severe deficit in 2 of 14 patients. Statistical analysis was performed to analyze the association between age, sex, history of hemorrhage before GKS, Spetzler-Martin grade, marginal dose, prior embolization before GKS, and AVM nidus volume, with potential relationship to increased chances of rebleeding after GKS, especially during the latency period. Only a Spetzler-Martin grade of III or less was significantly related to increased chances of hemorrhage after GKS (p < 0.002, Table 3 
Discussion
Radiosurgery offers a minimally invasive treatment for cerebral AVMs, the efficacy of which is well established in various reported studies. 6, 9, 19, 22, 30 The natural history of cerebral AVMs represents a risk of rebleeding varying from 2 to 4%, with a 1% risk of death and a 2.7% combined risk of major morbidity and death annually. 2, 5, 13, 15, 26 Patients remain at risk for rebleeding during the delay between treatment and complete obliteration, which is reported to be between 1 and 3 years after the treatment, with a hemorrhage rate varying from 3.4 to 10%; 6, 10, 14, 16, 19, 27 the rate was 2.7% in our study. Hemorrhage during the latency period is more common compared with rebleeding after complete angiographic obliteration, which nevertheless is being reported recently as data from longer follow-up periods after GKS are available. 22, 23, 29 Mortality rates following hemorrhage after radiosurgery have been reported to vary from 20 to 40% in various studies. 4, 7, 20, 23, 28 We, however, encountered relatively good outcome, with no deaths and only a 7% chance of sustaining a severe deficit; a figure quite less than in other studies. 4, 7, 20, 23, 28 Risk factors have been identified that predispose a patient to rebleeding after GKS, namely, angiographic factors like venous ectasia/stenosis/hypertension, the presence of intranidal aneurysm or periventricular location, lower marginal dose, large vol ume of the nidus, dose given to the nidus, and prior hem orrhage. 7, 10, 14, 17, 27 Individual analysis in our study did re veal an association between the presence of one of the angiographic factors mentioned above and rebleeding in almost all patients (12 of 14) . Male sex, the presence of deep venous drainage, prior hemorrhage, and volume < 10 cm 3 were also more common in patients with rebleeding after GKS. These are the same factors that are associated with increased chances of hemorrhagic presentation as reported in various studies, and the persistence of increased chances of rebleeding in these groups of patients may just reflect the progression of the natural history of the disease even after radiosurgery, especially in the initial period following GKS. 1, 5, 8, 12, 13, 21, 25, 26, 31 Increased risk of hemorrhage in patients with lower nidus volume (< 10 cm 3 ) is contradictory to other reported studies, which found increased chances of rebleeding with larger AVMs.
We observed that the hemorrhage risk remained until the complete obliteration of the nidus, with the maximum number of hemorrhages (58%) occurring in the 1st year after GKS.
Analysis of factors reported in various studies as well as in our series can provide insight about risk factors for bleeding after GKS and can lead to changes in treatment strategies such as use of adjunctive therapy in the form of targeted embolization, appropriate dose selection, and consideration of microsurgery in patients at high risk of postradiosurgical hemorrhage to decrease chances of hemorrhage during the latency period. Once it has occurred, the management of hemorrhage from an AVM after GKS should follow the same principles as with un- Fig. 3 . Lateral view of right internal carotid artery angiogram (a) and MR imaging study (b) of the brain showing a right frontal AVM, which was treated using GKS. The patient sustained an intraventricular hemorrhage in the follow-up study (c). Lateral view of right internal carotid artery angiogram (d) obtained after 7 years revealed a residual frontal AVM, which had decreased in size compared with pre-GKS studies, and was treated using repeat radiosurgery. treated ruptured AVMs, based on the lesion's location and the clinical status of the patient. In a significant number of patients, the AVM will tend to get obliterated if the hemorrhage is too early after GKS, in which case angiographic follow-up after either hematoma evacuation or conservative management should be the best treatment option, as reported in the present study and by Maruyama et al. 23 If the AVM persists for 4 or 5 years after the first GKS, hematoma evacuation if required and resection of the AVM if possible or repeat GKS is a feasible treatment. We had no experience with management of hemorrhage after complete obliteration because none of the AVMs in our cases bled after complete obliteration. However, we have started doing angiograms in patients with total obliteration, especially in children, to detect rare cases of recanalization of the AVM as reported in recent studies.
Conclusions
Hemorrhage, with its attendant risks of morbidity and death, forms the major reason for treating AVMs. With a period of latency until complete obliteration following GKS, the patient remains at risk for rebleeding, which can be fatal or can result in significant morbidity. Our study, however, shows that not only do very few patients experience rebleeding in the latency period, but the outcome in this subgroup of patients is good, with no deaths and minimal morbidity, an important parameter that does have therapeutic implications. 
